A detailed history of Appleton Partners Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Appleton Partners Inc holds 40,592 shares of ABBV stock, worth $8.28 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
40,592
Previous 41,793 2.87%
Holding current value
$8.28 Million
Previous $7.17 Million 11.83%
% of portfolio
0.59%
Previous 0.55%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$163.84 - $199.33 $196,771 - $239,395
-1,201 Reduced 2.87%
40,592 $8.02 Million
Q2 2024

Jul 02, 2024

SELL
$154.79 - $180.76 $74,763 - $87,307
-483 Reduced 1.14%
41,793 $7.17 Million
Q1 2024

Apr 01, 2024

SELL
$159.82 - $182.1 $250,757 - $285,714
-1,569 Reduced 3.58%
42,276 $7.7 Million
Q4 2023

Jan 02, 2024

SELL
$137.6 - $154.97 $187,136 - $210,759
-1,360 Reduced 3.01%
43,845 $6.8 Million
Q3 2023

Oct 03, 2023

SELL
$133.59 - $154.65 $135,059 - $156,351
-1,011 Reduced 2.19%
45,205 $6.74 Million
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $146,556 - $182,379
1,106 Added 2.45%
46,216 $6.23 Million
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $71,871 - $82,770
497 Added 1.11%
45,110 $7.19 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $71,506 - $85,754
-517 Reduced 1.15%
44,613 $7.21 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $36,773 - $42,176
-274 Reduced 0.6%
45,130 $6.06 Million
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $69,635 - $88,529
-506 Reduced 1.1%
45,404 $6.95 Million
Q1 2022

Apr 05, 2022

SELL
$131.98 - $163.75 $13,989 - $17,357
-106 Reduced 0.23%
45,910 $7.44 Million
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $156,955 - $198,593
1,461 Added 3.28%
46,016 $6.23 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $309,517 - $351,349
2,909 Added 6.99%
44,555 $4.81 Million
Q2 2021

Jul 07, 2021

BUY
$105.21 - $117.21 $60,495 - $67,395
575 Added 1.4%
41,646 $4.69 Million
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $46,341 - $51,016
-453 Reduced 1.09%
41,071 $4.45 Million
Q4 2020

Jan 19, 2021

SELL
$80.49 - $108.67 $874,765 - $1.18 Million
-10,868 Reduced 20.74%
41,524 $4.45 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $72,078 - $84,596
839 Added 1.63%
52,392 $4.59 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $32,796 - $43,886
-447 Reduced 0.86%
51,553 $5.06 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $172,408 - $261,392
-2,673 Reduced 4.89%
52,000 $3.96 Million
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $61,310 - $76,712
-850 Reduced 1.53%
54,673 $4.84 Million
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $389,027 - $467,722
-6,177 Reduced 10.01%
55,523 $4.2 Million
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $241,184 - $308,290
-3,671 Reduced 5.62%
61,700 $4.49 Million
Q1 2019

Apr 17, 2019

SELL
$77.14 - $90.79 $51,375 - $60,466
-666 Reduced 1.01%
65,371 $5.27 Million
Q4 2018

Jan 17, 2019

SELL
$77.85 - $96.01 $60,800 - $74,983
-781 Reduced 1.17%
66,037 $6.09 Million
Q3 2018

Oct 09, 2018

BUY
$88.91 - $98.84 $24,005 - $26,686
270 Added 0.41%
66,818 $6.32 Million
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $379,320 - $448,821
4,225 Added 6.78%
66,548 $6.17 Million
Q1 2018

Apr 11, 2018

BUY
$92.01 - $123.21 $67,627 - $90,559
735 Added 1.19%
62,323 $5.9 Million
Q4 2017

Jan 12, 2018

SELL
$89.56 - $98.21 $13,613 - $14,927
-152 Reduced 0.25%
61,588 $5.96 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $4.31 Million - $5.51 Million
61,740
61,740 $5.49 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.